AbbVie’s “patent thicket” strategy and aggressive drug pricing tactics have made it a prominent example of pharma finagling. But the company isn’t the only beneficiary.

It was an unexpected message: invest in Israeli health technology today in order to reap the benefits tomorrow of innovations spurred by the Israel-Gaza conflict.

A lawsuit spurred by a series of STAT stories accuses UnitedHealth of deploying an algorithm with a known high error rate, as investigative journalism flourishes.

It’s open enrollment season for Medicare, but star ratings for Medicare Advantage plans, meant to promote consumerism and value, can contain misleading information.

Grappling with what ChatGPT and generative AI will mean for health and medicine? The president of the National Academy of Medicine is both “excited” and “scared.”

The patient safety movement has succeeded in getting the president to consider their policy proposals, but if hospitals are hesitant, implementation will be difficulty

It’s hard to read the latest report on Medicare ACOs without feeling a tinge of sadness about what could ave been.

Hospital performance measures need to get beyond the failed report card format and present information in a way that resonates with the public.

Lives ruined by questionable artery clearing surgery and penis enlargement surgery both are connected to one controversial FDA rule.

“Every Man His Own Physician,” by Dr. John Theobald, bore an impressive subtitle: ” Being a complete collection of efficacious and approved remedies for every disease”